EP News: Clinical

Robinson et  al (Circulation 2019;139:313, PMID 30586734) prospectively evaluated noninvasive cardiac radioablation in adults with treatment-refractory episodes of ventricular tachycardia (VT) or cardiomyopathy related to premature ventricular contractions (PVCs). Arrhythmogenic scar was targeted using noninva sive anatomic and electric cardiac imaging with standard stereotactic body radiation. The primary safety end point was serious adverse events in the first 90 days. The primary efficacy end point was reduction in VT episodes or PVC burden.

Source: Heart Rhythm - February 21, 2019 Category: Cardiology Authors: N.A. Mark Estes Tags: EP News Source Type: research